Does PIMAVANSERIN Cause Salivary hypersecretion? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Salivary hypersecretion have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.2% of all adverse event reports for PIMAVANSERIN.
74
Reports of Salivary hypersecretion with PIMAVANSERIN
0.2%
of all PIMAVANSERIN reports
8
Deaths
18
Hospitalizations
How Dangerous Is Salivary hypersecretion From PIMAVANSERIN?
Of the 74 reports, 8 (10.8%) resulted in death, 18 (24.3%) required hospitalization, and 2 (2.7%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which PIMAVANSERIN Alternatives Have Lower Salivary hypersecretion Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE